These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 35685992)

  • 41. Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice.
    Zhao XH; Wang ZR; Chen CL; Di L; Bi ZF; Li ZH; Liu YM
    World J Gastroenterol; 2019 Jan; 25(1):138-150. PubMed ID: 30643364
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic analysis of invasive circulating tumor cells (iCTCs) in epithelial ovarian cancer.
    Pearl ML; Zhao Q; Yang J; Dong H; Tulley S; Zhang Q; Golightly M; Zucker S; Chen WT
    Gynecol Oncol; 2014 Sep; 134(3):581-90. PubMed ID: 24972191
    [TBL] [Abstract][Full Text] [Related]  

  • 43. EpCAM-independent isolation of circulating tumor cells with epithelial-to-mesenchymal transition and cancer stem cell phenotypes using ApoStream® in patients with breast cancer treated with primary systemic therapy.
    Le Du F; Fujii T; Kida K; Davis DW; Park M; Liu DD; Wu W; Chavez-MacGregor M; Barcenas CH; Valero V; Tripathy D; Reuben JM; Ueno NT
    PLoS One; 2020; 15(3):e0229903. PubMed ID: 32214335
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular characterization of circulating tumor cells in ovarian cancer.
    Kolostova K; Pinkas M; Jakabova A; Pospisilova E; Svobodova P; Spicka J; Cegan M; Matkowski R; Bobek V
    Am J Cancer Res; 2016; 6(5):973-80. PubMed ID: 27293992
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Detection of circulating tumor cells during follow-up of patients with early breast cancer: Clinical utility for monitoring of therapy efficacy.
    Mikulová V; Cabiňaková M; Janatková I; Mestek O; Zima T; Tesařová P
    Scand J Clin Lab Invest; 2014 Mar; 74(2):132-42. PubMed ID: 24350991
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients.
    Obermayr E; Sanchez-Cabo F; Tea MK; Singer CF; Krainer M; Fischer MB; Sehouli J; Reinthaller A; Horvat R; Heinze G; Tong D; Zeillinger R
    BMC Cancer; 2010 Dec; 10():666. PubMed ID: 21129172
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic impact of circulating tumor cells detected with the microfluidic "universal CTC-chip" for primary lung cancer.
    Kanayama M; Kuwata T; Mori M; Nemoto Y; Nishizawa N; Oyama R; Matsumiya H; Taira A; Shinohara S; Takenaka M; Yoneda K; Kuroda K; Ohnaga T; Tanaka F
    Cancer Sci; 2022 Mar; 113(3):1028-1037. PubMed ID: 34964211
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular characterization of circulating tumor cells in patients with ovarian cancer improves their prognostic significance -- a study of the OVCAD consortium.
    Obermayr E; Castillo-Tong DC; Pils D; Speiser P; Braicu I; Van Gorp T; Mahner S; Sehouli J; Vergote I; Zeillinger R
    Gynecol Oncol; 2013 Jan; 128(1):15-21. PubMed ID: 23017820
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Detection and Clinical Value of Circulating Tumor Cells as an Assisted Prognostic Marker in Colorectal Cancer Patients.
    Pan RJ; Hong HJ; Sun J; Yu CR; Liu HS; Li PY; Zheng MH
    Cancer Manag Res; 2021; 13():4567-4578. PubMed ID: 34135633
    [TBL] [Abstract][Full Text] [Related]  

  • 50. EpCAM-based Flow Cytometric Detection of Circulating Tumor Cells in Gallbladder Carcinoma Cases.
    Awasthi NP; Kumari S; Neyaz A; Gupta S; Agarwal A; Singhal A; Husain N
    Asian Pac J Cancer Prev; 2017 Dec; 18(12):3429-3437. PubMed ID: 29286615
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combined detection and subclass characteristics analysis of CTCs and CTECs by SE-iFISH in ovarian cancer.
    Cheng H; Wang S; Luan W; Ye X; Dou S; Tang Z; Zhu H; Lin PP; Li Y; Cui H; Chang X
    Chin J Cancer Res; 2021 Apr; 33(2):256-270. PubMed ID: 34158744
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Highly sensitive detection and mutational analysis of lung cancer circulating tumor cells using integrated combined immunomagnetic beads with a droplet digital PCR chip.
    Gao W; Huang T; Yuan H; Yang J; Jin Q; Jia C; Mao G; Zhao J
    Talanta; 2018 Aug; 185():229-236. PubMed ID: 29759193
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CD44v6 Defines a New Population of Circulating Tumor Cells Not Expressing EpCAM.
    Belthier G; Homayed Z; Grillet F; Duperray C; Vendrell J; Krol I; Bravo S; Boyer JC; Villeronce O; Vitre-Boubaker J; Heaug-Wane D; Macari-Fine F; Smith J; Merlot M; Lossaint G; Mazard T; Portales F; Solassol J; Ychou M; Aceto N; Mamessier E; Bertucci F; Pascussi JM; Samalin E; Hollande F; Pannequin J
    Cancers (Basel); 2021 Oct; 13(19):. PubMed ID: 34638450
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Circulating Tumor Cells Detection in Patients with Early Breast Cancer Using MACS Immunomagnetic Flow Cytometry.
    Karimi N; Oloomi M; Orafa Z
    Avicenna J Med Biotechnol; 2020; 12(3):148-156. PubMed ID: 32695277
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical Significance of Mesenchymal Circulating Tumor Cells in Patients With Oligometastatic Hormone-Sensitive Prostate Cancer Who Underwent Cytoreductive Radical Prostatectomy.
    Yang G; Xie J; Zhang S; Gu W; Yuan J; Wang R; Guo C; Ye L; Peng B; Yao X; Yang B
    Front Oncol; 2021; 11():812549. PubMed ID: 35127528
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical significance of MUC1 and c-Met RT-PCR detection of circulating tumor cells in patients with gastric carcinoma.
    Uen YH; Lin SR; Wu CH; Hsieh JS; Lu CY; Yu FJ; Huang TJ; Wang JY
    Clin Chim Acta; 2006 May; 367(1-2):55-61. PubMed ID: 16403482
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multimarker Analysis of Circulating Tumor Cells in Peripheral Blood of Metastatic Breast Cancer Patients: A Step Forward in Personalized Medicine.
    de Albuquerque A; Kaul S; Breier G; Krabisch P; Fersis N
    Breast Care (Basel); 2012 Feb; 7(1):7-12. PubMed ID: 22553466
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Detection and cultivation of circulating tumor cells in gastric cancer.
    Kolostova K; Matkowski R; Gürlich R; Grabowski K; Soter K; Lischke R; Schützner J; Bobek V
    Cytotechnology; 2016 Aug; 68(4):1095-102. PubMed ID: 25862542
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Filtration based assessment of CTCs and CellSearch® based assessment are both powerful predictors of prognosis for metastatic breast cancer patients.
    Huebner H; Fasching PA; Gumbrecht W; Jud S; Rauh C; Matzas M; Paulicka P; Friedrich K; Lux MP; Volz B; Gass P; Häberle L; Meier-Stiegen F; Hartkopf A; Neubauer H; Almstedt K; Beckmann MW; Fehm TN; Ruebner M
    BMC Cancer; 2018 Feb; 18(1):204. PubMed ID: 29463222
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multicolor detection of rare tumor cells in blood using a novel flow cytometry-based system.
    Watanabe M; Uehara Y; Yamashita N; Fujimura Y; Nishio K; Sawada T; Takeda K; Koizumi F; Koh Y
    Cytometry A; 2014 Mar; 85(3):206-13. PubMed ID: 24327318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.